HuGE Literature Finder
Records 1-15
|
High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population.
Hereditary cancer in clinical practice 2018 16 12. Maksimenko J, Irmejs A, Trofimovi?s G, B?rzi?a D, Skuja E, Purkalne G, Miklaševi?s E, Gardovskis |
|
Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer.
BMC cancer 2018 01 18 (1): 83. Park Ji Soo, Lee Seung-Tae, Nam Eun Ji, Han Jung Woo, Lee Jung-Yun, Kim Jieun, Kim Tae Il, Park Hyung Se |
|
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
JAMA oncology 2017 Sep 3 (9): 1190-1196. Couch Fergus J, Shimelis Hermela, Hu Chunling, Hart Steven N, Polley Eric C, Na Jie, Hallberg Emily, Moore Raymond, Thomas Abigail, Lilyquist Jenna, Feng Bingjian, McFarland Rachel, Pesaran Tina, Huether Robert, LaDuca Holly, Chao Elizabeth C, Goldgar David E, Dolinsky Jill |
|
Next-Generation Sequencing Reveals a Nonsense Mutation (p.Arg364Ter) in MRE11A Gene in an Indian Patient with Familial Breast Cancer.
Breast care (Basel, Switzerland) 2017 May 12 (2): 114-116. Sharma Bhai Pratibha, Sharma Deepak, Saxena Renu, Verma Ishwar |
|
Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP53.
International journal of cancer 2017 08 141 (4): 750-756. Lolas Hamameh Suhair, Renbaum Paul, Kamal Lara, Dweik Dima, Salahat Mohammad, Jaraysa Tamara, Abu Rayyan Amal, Casadei Silvia, Mandell Jessica B, Gulsuner Suleyman, Lee Ming K, Walsh Tom, King Mary-Claire, Levy-Lahad Ephrat, Kanaan Moe |
|
Multigene testing of moderate-risk genes: be mindful of the missense.
Journal of medical genetics 2016 06 53 (6): 366-76. Young E L, Feng B J, Stark A W, Damiola F, Durand G, Forey N, Francy T C, Gammon A, Kohlmann W K, Kaphingst K A, McKay-Chopin S, Nguyen-Dumont T, Oliver J, Paquette A M, Pertesi M, Robinot N, Rosenthal J S, Vallee M, Voegele C, Hopper J L, Southey M C, Andrulis I L, John E M, Hashibe M, Gertz J, , Le Calvez-Kelm F, Lesueur F, Goldgar D E, Tavtigian S |
|
Detection of novel germline mutations for breast cancer in non-BRCA1/2 families.
The FEBS journal 2015 Sep 282 (17): 3424-37. Aloraifi Fatima, McDevitt Trudi, Martiniano Rui, McGreevy Jonah, McLaughlin Russell, Egan Chris M, Cody Nuala, Meany Marie, Kenny Elaine, Green Andrew J, Bradley Daniel G, Geraghty James G, Bracken Adrian |
|
Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China.
Molecular genetics and genomics : MGG 2015 Jun 290 (3): 1141-53. Wu Zhenzhen, Wang Peng, Song Chunhua, Wang Kaijuan, Yan Rui, Li Jingruo, Dai Lipi |
|
Expanding the genetic basis of copy number variation in familial breast cancer.
Hereditary cancer in clinical practice 2014 12 (1): 15. Masson Amy L, Talseth-Palmer Bente A, Evans Tiffany-Jane, Grice Desma M, Hannan Garry N, Scott Rodney |
|
Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study.
Breast cancer research : BCR 2014 16 (3): R58. Damiola Francesca, Pertesi Maroulio, Oliver Javier, Le Calvez-Kelm Florence, Voegele Catherine, Young Erin L, Robinot Nivonirina, Forey Nathalie, Durand Geoffroy, Vallée Maxime P, Tao Kayoko, Roane Terrell C, Williams Gareth J, Hopper John L, Southey Melissa C, Andrulis Irene L, John Esther M, Goldgar David E, Lesueur Fabienne, Tavtigian Sean |
|
Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study.
Genes, chromosomes & cancer 2013 Jul 52 (7): 595-609. Pellatt Andrew J, Wolff Roger K, Torres-Mejia Gabriela, John Esther M, Herrick Jennifer S, Lundgreen Abbie, Baumgartner Kathy B, Giuliano Anna R, Hines Lisa M, Fejerman Laura, Cawthon Richard, Slattery Martha |
|
Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.
Human mutation 2012 Jan 33 (1): 158-64. Brooks Jennifer D, Teraoka Sharon N, Reiner Anne S, Satagopan Jaya M, Bernstein Leslie, Thomas Duncan C, Capanu Marinela, Stovall Marilyn, Smith Susan A, Wei Shan, Shore Roy E, Boice John D, Lynch Charles F, Mellemkjaer Lene, Malone Kathleen E, Liang Xiaolin, , Haile Robert W, Concannon Patrick, Bernstein Jonine |
|
Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes.
Cancer research 2011 Sep 71 (17): 5792-805. Rebbeck Timothy R, Mitra Nandita, Domchek Susan M, Wan Fei, Friebel Tara M, Tran Teo V, Singer Christian F, Tea Muy-Kheng Maria, Blum Joanne L, Tung Nadine, Olopade Olufunmilayo I, Weitzel Jeffrey N, Lynch Henry T, Snyder Carrie L, Garber Judy E, Antoniou Antonis C, Peock Susan, Evans D Gareth, Paterson Joan, Kennedy M John, Donaldson Alan, Dorkins Huw, Easton Douglas F, , Rubinstein Wendy S, Daly Mary B, Isaacs Claudine, Nevanlinna Heli, Couch Fergus J, Andrulis Irene L, Freidman Eitan, Laitman Yael, Ganz Patricia A, Tomlinson Gail E, Neuhausen Susan L, Narod Steven A, Phelan Catherine M, Greenberg Roger, Nathanson Katherine |
|
Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population.
Breast cancer research and treatment 2010 May 121 (1): 147-56. Loizidou Maria A, Cariolou Marios A, Neuhausen Susan L, Newbold Robert F, Bashiardes Evy, Marcou Yiola, Michael Thalia, Daniel Maria, Kakouri Eleni, Papadopoulos Panayiotis, Malas Simon, Hadjisavvas Andreas, Kyriacou Kyriac |
|
DNA-repair genetic polymorphisms and risk of breast cancer in Cyprus.
Breast cancer research and treatment 2008 Jun . Loizidou MA, Michael T, Neuhausen SL, Newbold RF, Marcou Y, Kakouri E, Daniel M, Papadopoulos P, Malas S, Hadjisavvas A, Kyriacou K |
- Page last reviewed:Oct 1, 2020
- Page last updated:Mar 08, 2021
- Content source: